|
Session 146
Poster Abstracts
ART and Hepatoxicity
Monday, 1 - 4 pm
Poster Hall |
821
 |
Liver Disease of Unknown Etiology in HIV-infected Patients: Prevalence, Clinical Presentation, and Putative Causes
Pablo Barreiro*, I Maida, L Martín-Carbonero, F Blanco, P Labarga, C Castellares, A Ruíz-Sancho, J González-Lahoz, and V Soriano
Hosp Carlos III, Madrid, Spain |
822
|
Hepatic Steatosis and Liver Function Abnormalities among HIV-infected Persons
Nancy Crum-Cianflone*1,2, Nancy Crum-Cianflone*1,2, C Hames1, S Medina1,2, S Medina1,2, R Campin1, T Capozza1, C Brandt1,2, C Brandt1,2, D Asher1, B Hale1,2, B Hale1,2, and the TriService AIDS Clinical Consortium
1Naval Med Ctr, San Diego, CA, US and 2TriSvc AIDS Clin Consortium, Lackland AFB, TX, US |
823
|
Gilbert’s Disease and Atazanavir: From Phenotype to UDP-glucuronosyltransferease Haplotype
T Lankisch, Georg Behrens*, U Moebius, M Wehmeier, M Manns, and C Strassburg
Hannover Med Sch, Germany |
| 824 |
HIV RNA Suppression following Liver and Kidney Transplantation
Michelle Roland*1, B Barin2, M Wong3, M Keller4, M Ragni5, D Hardy6, E Blumberg7, J Feinberg8, D Stablein2, and P Stock1
1Univ of California, San Francisco, US; 2EMMES Corp, Rockville, MD, US; 3Beth Israel Deaconess Med Ctr, Boston, MA, US; 4Mt Sinai Med Ctr, New York, NY, US; 5Univ of Pittsburgh, PA, US; 6Cedars-Sinai Med Ctr, Los Angeles, CA, US; 7Univ of Pennsylvania, Philadelphia, US; and 8Univ of Cincinnati, OH, US |
|
